Cargando…

T219. THE ROLE OF MELATONIN AND MELATONIN AGONISTS IN COUNTERACTING ANTIPSYCHOTIC-INDUCED METABOLIC SIDE EFFECTS: A SYSTEMATIC REVIEW

BACKGROUND: Melatonin administration to high cholesterol-treated and high fat-treated rats has been shown to suppress body weight and visceral adiposity. In addition, in various animal models related to obesity, metabolic syndrome, and diabetes, melatonin has beneficial efficacy in ameliorating vari...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bahk, Won-Myong, Kwon, Young Joon, Yoon, Bo-Hyun, Lee, Sang-Yeol, Lee, Kwanghun, Jon, Duk-In, Kim, Moon Doo, Lim, Eunsung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887358/ http://dx.doi.org/10.1093/schbul/sby016.495

Ejemplares similares

S220. BLONANSERIN AUGMENTATION IN PATIENTS WITH SCHIZOPHRENIA – WHO IS BENEFITED FROM BLONANSERIN AUGMENTATION? AN OPEN-LABEL, PROSPECTIVE, MULTI-CENTER STUDY
por: Bahk, Won-Myong, et al.
Publicado: (2018)

F45. THE EFFICACY AND SAFETY OF BLONASERIN AFTER SWITCHING FROM OTHER ATYPICAL ANTIPSYCHOTICS IN SCHIZOPHRENIC INPATIENTS: AN OPEN-LABEL, MULTI-CENTER TRIAL
por: Yoon, Bo-Hyun, et al.
Publicado: (2018)

Does Melatonin and Melatonin Agonists Improve the Metabolic Side Effects of Atypical Antipsychotics?: A Systematic Review and Meta-analysis of Randomized Controlled Trials
por: Igwe, Stanley C., et al.
Publicado: (2018)

S7. NEOSENSITIZATION TO MULTIPLE DRUGS FOLLOWING DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS SYNDROME (DRESS)
por: Kim, Moon Doo, et al.
Publicado: (2018)

F194. ASSOCIATION STUDY BETWEEN TREATMENT RESPONSE OF AMISULPRIDE AND DOPAMINE D3 RECEPTOR GENE POLYMORPHISMS
por: Lee, Kwanghun, et al.
Publicado: (2018)

T116. CAFFEINE-INDUCED PSYCHIATRIC MANIFESTATIONS
por: Lee, Kwanghun, et al.
Publicado: (2018)

M185. THE EFFECTS OF GROUP ARTS THERAPY BASED ON EMOTION MANAGEMENT TRAINING ON THE EMOTIONAL EXPRESSION, ALEXITHYMIA, DEPRESSION AND QUALITY OF LIFE IN PATIENTS WITH SCHIZOPHRENIA
por: Lim, Eunsung, et al.
Publicado: (2020)

M46. THE STUDY OF HEART RATE VARIABILITY AND EMOTIONAL RESPONSE TO POSITIVE AND NEGATIVE AUDIOVISUAL STIMULATION IN PATIENTS WITH SCHIZOPHRENIA
por: Jang, Seung-Ho, et al.
Publicado: (2020)

Mood Disorders, Circadian Rhythms, Melatonin and Melatonin Agonists
por: Quera Salva, M.A., et al.
Publicado: (2012)

Can melatonin prevent or improve metabolic side effects during antipsychotic treatments?
por: Porfirio, Maria-Cristina, et al.
Publicado: (2017)

F213. THE EFFECTS OF GROUP INTEGRATIVE ARTS THERAPY BASED ON SOCIAL SKILL TRAINING ON THE SOCIAL ADAPTIVE FUNCTION, EMPOWERMENT AND SUBJECTIVE WELL-BEING IN INPATIENTS WITH CHRONIC SCHIZOPHRENIA
por: Lim, Eunsung, et al.
Publicado: (2018)

S110. THE CLINICAL IMPLICATION OF CLINICIAN-RATED DIMENSIONS OF PSYCHOSIS SYMPTOM SEVERITY (CRDPSS) FOR DIAGNOSIS BY DSM-5
por: Nam, Beomwoo, et al.
Publicado: (2018)

T230. DOSE TRENDS OF ARIPIPRAZOLE FROM 2004 TO 2014 IN PSYCHIATRIC INPATIENTS IN KOREA
por: Kwon, Young-Joon, et al.
Publicado: (2018)

S196. ASSOCIATION BETWEEN INTRACELLULAR INFECTIOUS AGENTS AND SCHIZOPHRENIA IN KOREA
por: Kwon, Young-Joon, et al.
Publicado: (2018)

F3. A CASE OF LEUKOCYTOSIS ASSOCIATED WITH CLOZAPINE TREATMENT FOR THE MANAGEMENT OF CHRONIC SCHIZOPHRENIA
por: Song, Min-Kyu, et al.
Publicado: (2018)

Melatonin and Exercise Counteract Sarcopenic Obesity through Preservation of Satellite Cell Function
por: Mankhong, Sakulrat, et al.
Publicado: (2023)

T251. THE STUDY OF QUALITY OF LIFE AND A GLOBAL FUNCTIONING FOR THE SCHIZOPHRENIA PATIENTS IN COMMUNITY BY THEIR RESIDENTIAL ENVIRONMENT
por: Lee, Sang-Yeol, et al.
Publicado: (2018)

F115. INSIGHT AND MANIC SYMPTOMS IN PATIENTS WITH CHRONIC SCHIZOPHRENIA IN THE KOREAN COMMUNITY
por: Jon, Duk-In, et al.
Publicado: (2018)

The Neuroprotective Effects of Melatonin: Possible Role in the Pathophysiology of Neuropsychiatric Disease
por: Lee, Jung Goo, et al.
Publicado: (2019)

Suppression of Osteoclastogenesis by Melatonin: A Melatonin Receptor-Independent Action
por: Kim, Hyung Joon, et al.
Publicado: (2017)

Clinical assessment of bipolar depression: validity, factor structure and psychometric properties of the Korean version of the Bipolar Depression Rating Scale (BDRS)
por: Jung, Young-Eun, et al.
Publicado: (2016)

Melatonin and Melatonin Agonists for Prevention of Delirium in the Cardiac Surgical ICU: A Meta-analysis
por: Niyogi, Subhrashis Guha, et al.
Publicado: (2023)

F223. COMPARATIVE STUDY OF HEART RATE VARIABILITY AND EMOTIONAL RESPONSE TO POSITIVE AND NEGATIVE AUDIOVISUAL STIMULATION IN PATIENTS WITH CHRONIC SCHIZOPHRENIA AND HEALTHY CONTROL
por: Lee, Sang-Yeol, et al.
Publicado: (2018)

Melatonin and melatonin agonists to prevent and treat delirium in critical illness: a systematic review protocol
por: Foster, Jennifer, et al.
Publicado: (2016)

The genomic response of human granulosa cells (KGN) to melatonin and specific agonists/antagonists to the melatonin receptors
por: Arjoune, Asma, et al.
Publicado: (2022)

Switching Antipsychotics to Blonanserin in Patients with Schizophrenia: An Open-label, Prospective, Multicenter Study
por: Woo, Young Sup, et al.
Publicado: (2019)

Melatonin Supplement Plus Exercise Effectively Counteracts the Challenges of Isoproterenol-Induced Cardiac Injury in Rats
por: Rahman, Md. Mahbubur, et al.
Publicado: (2023)

T77. ASSOCIATION BETWEEN INTRACELLULAR INFECTIOUS AGENTS AND SCHIZOPHRENIA
por: Kwon, Young-Joon, et al.
Publicado: (2020)

S219. RISK FACTORS FOR LOW BONE MINERAL DENSITY IN PATIENTS TAKING ANTIPSYCHOTICS
por: Jhon, Min, et al.
Publicado: (2018)

New MT(2) Melatonin Receptor-Selective Ligands: Agonists and Partial Agonists
por: Boutin, Jean A., et al.
Publicado: (2017)

Melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, attenuates TNBS-induced colitis in mice
por: Zielińska, Marta, et al.
Publicado: (2016)

High membrane permeability for melatonin
por: Yu, Haijie, et al.
Publicado: (2016)

Therapeutic Effects of Melatonin Receptor Agonists on Sleep and Comorbid Disorders
por: Laudon, Moshe, et al.
Publicado: (2014)

Melatonin Receptors Agonistic Activities of Phenols from Gastrodia elata
por: Chen, Si-Yue, et al.
Publicado: (2019)

Structure-based discovery of potent and selective melatonin receptor agonists
por: Patel, Nilkanth, et al.
Publicado: (2020)

Mammalian Melatonin Agonist Pharmaceuticals Stimulate Rhomboid Proteins in Plants
por: Erland, Lauren A. E., et al.
Publicado: (2022)

Melatonin
por: Pévet, Paul
Publicado: (2002)

Melatonin–Microbiome Two-Sided Interaction in Dysbiosis-Associated Conditions
por: Iesanu, Mara Ioana, et al.
Publicado: (2022)

Altered Expression of DAAM1 and PREP Induced by Cadmium Toxicity Is Counteracted by Melatonin in the Rat Testis
por: Venditti, Massimo, et al.
Publicado: (2021)

Melatonin and Its Agonist Ramelteon in Alzheimer's Disease: Possible Therapeutic Value
por: Srinivasan, Venkatramanujam, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_12vp9uica2e2mn6tj043mqejus